ON Semiconductor Raises $1.3B Via Upsized Private Note Offering For Debt Repayment
Today, 10:07 AM
ON Semiconductor Corp (NASDAQ:ON) raised $1.3 billion via an upsized institutional offering of 0.50% convertible senior notes due 2029. The…
Why Sellas Life Sciences Shares Are Nosediving
Today, 10:07 AM
Sellas Life Sciences Group Inc (NASDAQ: SLS) shares are trading lower by 52.57% to $1.75 Friday morning after the company announced pricing of a $20 million underwritten public offering.
What Else?
Infobird Co., Ltd Announces Pricing Of $5 Million Registered Direct Offering Of 3,846,000 Units, Consisting Of One Share And 0.65 Warrant To Purchase A Share At A Price Of $1.30/Unit
Today, 10:07 AM
Infobird Co., Ltd (NASDAQ:IFBD) ("Infobird" or the "Company"), a leading and long-standing SaaS providers in serving large enterprises in the finance industry in customer engagement with over 10
Reported Late Thursday Feb 23, Tactile Systems Technology, Inc. Announces Pricing Of $32.5M Public Offering Of 2.5M Shares Of Common Stock At A Price Of $13/Share
Today, 10:07 AM
Tactile Systems Technology, Inc. ("Tactile Medical") (NASDAQ:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases
Reported Late Wednesday Feb 22, Apellis Pharmaceuticals Announces Pricing Of $350M Public Offering Of 3,174,603 Shares Of Common Stock At A Price Of $63/Share And Pre-Funded Warrants To Purchase 2,380,956 Shares Of Common Stock At A Price Of $62.99/Sha…
Today, 10:07 AM
Apellis Pharmaceuticals, Inc., (NASDAQ:APLS), a global biopharmaceutical company and leader in complement, today announced the pricing of its underwritten public offering of 3,174,603 shares of its common
Reported Late Wednesday Feb 22, Aprea Therapeutics Announces Pricing Of $5.5M Underwritten Public Offering Of 1.05M Shares Of Common Stock At A Price Of $5.25/Share
Today, 10:07 AM
Aprea Therapeutics, Inc. (NASDAQ:APRE) ("Aprea", or the "Company"), a biopharmaceutical company focused on developing novel synthetic lethality-based cancer therapeutics targeting DNA damage response
Why Quoin Pharmaceuticals Shares Are Getting Obliterated Wednesday
Today, 10:07 AM
Quoin Pharmaceuticals Ltd - ADR (NASDAQ: QNRX) shares are trading lower by 42.82% to $0.68 Wednesday morning. The company announced pricing of its $7 million public offering.
What Else?
Why Canopy Growth Shares Are Getting Smoked Today
Today, 10:07 AM
Canopy Growth Corp (NASDAQ: CGC) shares are trading lower Tuesday after the company announced a $150 million registered direct offering.